Skip to main content

GlyciWave Glycine

Neuraldrink™

3,000 mg (3g)

Clinical Dose

Research-Validated

Form

Pharmaceutical-Grade Powder

Solubility

Excellent (Beverage-Ready)
The amino acid that cools you into sleep and powers you through tomorrow. Glycine is the simplest amino acid by structure, yet one of the most profoundly versatile in function. At the clinical dose of 3 grams — precisely what Neuraldrink delivers — glycine initiates a thermoregulatory cascade that lowers core body temperature by ~0.3°C, signaling the brain that it’s time to sleep. But this is just the beginning: glycine also acts as an inhibitory neurotransmitter (promoting calm), an NMDA receptor co-agonist (supporting learning and memory), and a precursor to glutathione (the body’s master antioxidant). Clinical trials demonstrate that 3g glycine before bed shortens sleep latency, improves sleep efficiency, and — remarkably — enhances next-day cognitive performance and reduces fatigue. Its natural sweetness and exceptional water solubility make glycine the ideal functional beverage ingredient. In Neuraldrink, GlyciWave Glycine transforms your evening ritual into a scientifically-validated pathway to better sleep and sharper mornings.
Glycine exerts its effects through four distinct but interconnected mechanisms:

Mechanism 1: Thermoregulatory Cascade (Primary Sleep Mechanism)

This is glycine’s most distinctive mechanism — and the key to its sleep-promoting effects:
StepPhysiological EventMagnitude
1. AbsorptionGlycine crosses BBBWithin 30-60 min
2. SCN activationNMDA receptors in suprachiasmatic nucleusDose-dependent
3. VasodilationPeripheral blood vessel dilationMeasurable ↑ blood flow
4. Heat dissipationHeat loss through extremities~0.28-0.3°C drop
5. Sleep signalCore cooling triggers sleep onsetFaster sleep latency
Why temperature matters for sleep: The body naturally cools by 1-2°C during sleep onset. This temperature drop is not merely correlated with sleep — it’s causally involved in initiating it. Glycine accelerates this natural process by activating peripheral heat loss mechanisms.

Mechanism 2: Inhibitory Neurotransmission

Glycine is a major inhibitory neurotransmitter in the brainstem and spinal cord:
ParameterEffect
ReceptorGlycine Receptor (GlyR) — chloride channel
Ion movementCl⁻ influx → hyperpolarization
Net effectReduced neuronal firing
Brain regionsBrainstem, spinal cord, retina
Functional outcomeCalming, muscle relaxation

Mechanism 3: NMDA Receptor Co-Agonism

Glycine has a dual role — it’s also an obligatory co-agonist at excitatory NMDA receptors:
NMDA FunctionGlycine’s RoleCognitive Relevance
Receptor activationRequired co-agonistEnables NMDA function
Calcium influxModulates magnitudeSignal strength
LTP inductionFacilitatesMemory consolidation
Synaptic plasticitySupportsLearning capacity
The dual role paradox: How can glycine be both inhibitory (calming) and excitatory (NMDA co-agonist)? The answer lies in location and receptor type:
  • GlyR receptors (inhibitory): Predominant in brainstem/spinal cord → calming
  • NMDA receptors (excitatory): Predominant in cortex/hippocampus → cognition
This dual action allows glycine to calm the body while supporting cognitive function.

Mechanism 4: Glutathione Precursor

Glycine is one of three amino acids required to synthesize glutathione:
GSH ComponentSourceLimiting Factor
GlutamateAbundantRarely limiting
CysteineDiet, NACOften limiting
GlycineDiet, synthesisCan be limiting
Glycine availability can be rate-limiting for glutathione synthesis, especially in:
  • Low-protein diets
  • Elderly individuals
  • High oxidative stress states

Complete Mechanism Summary

MechanismReceptor/TargetEffectTimeline
ThermoregulationNMDA (SCN)Core temp ↓ 0.3°C30-60 min
Inhibitory NTGlyRNeural calmingAcute
NMDA co-agonismNMDA-RLTP, plasticityAcute + chronic
GSH precursorSynthesis pathwayAntioxidant ↑Chronic

Why Temperature Is the Master Sleep Switch

The relationship between body temperature and sleep is one of the most fundamental in chronobiology:
TimeCore TemperatureSleep State
Afternoon~37.0-37.2°CPeak alertness
Evening~36.8°CWinding down
Sleep onset~36.5°CSleep-permissive
Sleep nadir~36.0°CDeep sleep
Pre-wakeRisingPreparation for waking
The 0.3°C threshold: Research shows that a drop of approximately 0.3°C in core temperature is associated with sleep onset. Glycine accelerates this natural drop.

The SCN Connection

The suprachiasmatic nucleus (SCN) is the brain’s master circadian clock:Key research findings:
  • Glycine activates NMDA receptors in the SCN (Kawai et al., 2015)
  • NMDA antagonists (AP5, CGP78608) block glycine’s temperature effects
  • Glycine receptor antagonists (strychnine) do not block the effect
  • This confirms the NMDA-mediated thermoregulatory mechanism

Cutaneous Blood Flow Evidence

MeasurementPlaceboGlycine 3gChange
Plantar blood flowBaseline↑ SignificantDose-dependent
Core temperature36.8°C36.5°C−0.28°C
Sleep latency13.5 min10.7 min−21%

Why This Mechanism Is Superior

Sleep AidMechanismMorning After
BenzodiazepinesGABA-A agonismGrogginess, impairment
Z-drugsGABA-A agonismPotential hangover
AntihistaminesH1 blockadeSignificant impairment
GlycineNatural thermoregulationEnhanced cognition
Glycine works with the body’s natural sleep architecture rather than overriding it. This explains why glycine improves next-day performance rather than impairing it.

The Japanese Sleep Studies

The foundational research on glycine and sleep comes from Ajinomoto’s research program in Japan:

Yamadera 2007 — The Landmark Study

ParameterDesign
Population11 adults with chronic sleep dissatisfaction
Intervention3g glycine vs placebo, before bedtime
MeasurementsPSG, subjective sleep quality, daytime cognition
DesignRandomized, double-blind, placebo-controlled, crossover
Results:
OutcomePlaceboGlycineP-value
Sleep latency13.5 ± 3.2 min10.7 ± 2.8 min<0.05
Latency to SWS7.4 ± 2.5 min5.8 ± 2.2 min<0.05
Sleep efficiency89.2%92.1%<0.05
Subjective qualitySignificantly improved<0.05
Crucially: Sleep architecture (REM/NREM proportions) was preserved — glycine doesn’t distort natural sleep stages.

Bannai 2012 — Sleep Restriction Model

ParameterDesign
Model25% sleep restriction (6h instead of 8h)
Intervention3g glycine before restricted sleep
OutcomesNext-day fatigue, sleepiness, performance
Results:
OutcomeWithout GlycineWith GlycineImprovement
Daytime fatigueHighReduced~15%
Sleepiness (SSS)ElevatedReduced~29%
AlertnessImpairedImprovedSignificant

Next-Day Cognitive Benefits

This is what makes glycine unique among sleep aids:
Cognitive DomainEffectStudy
Memory recognition↑ ImprovedYamadera 2007
Word recall↑ ImprovedMultiple
Reaction timeMaintained/improvedBannai 2012
Subjective clarity”Clear-headedness” ↑Yamadera 2007
”Liveliness and peppiness”↑ ReportedYamadera 2007

Effect Timeline

NightSleep EffectNext-Day Effect
Night 1Often noticeableSubtle
Night 3-5Consistent improvementBuilding
Night 7+Full effectMaximal cognitive benefit
The Glycine Paradox Resolved: Unlike sedative sleep aids that impair next-day function, glycine improves it. This is because glycine works through natural thermoregulation rather than GABA-A sedation, preserving sleep architecture and cognitive function.

Glycine as a Glutathione Precursor

Glutathione (GSH) is the body’s “master antioxidant” — and glycine is essential for its synthesis:

Why Glycine Matters for GSH

FactorImplication
Rate-limitingGlycine can limit GSH synthesis
Age-related declineElderly have lower glycine and GSH
Dietary insufficiencyModern diets often low in glycine
High demand statesOxidative stress depletes GSH

The GlyNAC Research

Combining Glycine + N-Acetylcysteine (GlyNAC) has shown remarkable effects:
Study (Kumar et al.)Finding
PopulationOlder adults
InterventionGlycine + NAC supplementation
GSH levelsRestored to young adult levels
Oxidative stressSignificantly reduced
Mitochondrial functionImproved

Antioxidant Cascade

Beyond Antioxidant: Glycine’s Protective Roles

Protective FunctionMechanismEvidence
Anti-inflammatory↓ NF-κB, ↓ TNF-α, IL-6Multiple studies
HepatoprotectiveGSH support, direct effectsAnimal + human data
CytoprotectiveMembrane stabilizationEstablished
NeuroprotectiveGSH + NMDA modulationEmerging

Metabolic Benefits

Glycine has additional metabolic effects beyond antioxidant support:
Metabolic EffectMechanismRelevance
Insulin sensitivity↑ Glucose uptakeMetabolic health
Lipid metabolismBile acid conjugationDigestion, cholesterol
One-carbon metabolismSerine-glycine interconversionMethylation, DNA synthesis

Why Glycine Is Perfect for Neuraldrink

Glycine possesses ideal properties for functional beverage formulation:

Solubility Comparison

IngredientSolubility (g/100mL)Beverage Suitability
Glycine~25Excellent
L-Theanine~5Good
Magnesium glycinate~10Good
L-Tyrosine~0.5Poor
Creatine~1.5Moderate

Taste Profile

PropertyValueBeverage Implication
Sweetness~0.7× sucroseReduces added sweetener
AftertasteNoneClean finish
BitternessNoneNo masking needed
UmamiSlightDepth of flavor
The name “glycine” derives from Greek glykys meaning “sweet” — discovered in 1820 when Henri Braconnot noted its sweet taste.

Stability

ConditionStabilityNotes
HeatExcellentSurvives pasteurization
pH 3-8ExcellentStable across beverage range
LightExcellentNo photodegradation
OxidationExcellentNot susceptible
Shelf life2+ yearsAs powder; extended in formulation

Clinical Dose Delivery

The 3g clinical dose is easily achieved in beverage format:
FormatTypical VolumeGlycine ConcentrationPalatability
Neuraldrink250-350 mL~1% w/vExcellent
Shot60 mL~5% w/vGood
Powder sachetReconstitutedVariableExcellent

Synergy in Neuraldrink

Glycine complements other Neuraldrink ingredients:
IngredientGlycine SynergyCombined Benefit
L-TheanineBoth promote calmEnhanced relaxation
MagnesiumBoth support NMDA functionSleep + cognitive
ElectrolytesGlycine aids absorptionHydration support
Formulation Excellence: Glycine’s exceptional solubility (~25g/100mL), natural sweetness, and complete stability make it one of the most beverage-compatible bioactives available. The clinical 3g dose dissolves instantly and contributes pleasant sweetness without any off-flavors.

ADME Parameters

ParameterValueNotes
BioavailabilityHigh (oral)Efficient intestinal absorption
Tmax~1-2 hoursPeak plasma levels
BBB penetrationYesCrosses via transporters
CSF accumulationYesDistributes to brain
Half-life~3-4 hoursModerate duration
MetabolismMultiple pathwaysSerine conversion, GSH, etc.
ExcretionRenal (minimal unchanged)Extensively metabolized

Absorption and Distribution

Plasma and Effect Timeline

Time After DosePlasma LevelCNS LevelFunctional Effect
0 minBaselineBaselineNone
30 minRisingRisingMinimal
60 minNear peakRisingThermoregulation begins
90 minPeakPeakSleep-promoting effect
2-4 hoursDecliningSustainedSleep maintenance
Next morningLowResidualCognitive enhancement

Optimal Timing

ScenarioTimingRationale
Sleep optimization30-60 min before bedPeak effect at sleep onset
Neuraldrink1 hour before bedAllows absorption time
With mealAcceptableSlightly delayed absorption
Empty stomachPreferredFaster absorption

Dose-Response

DoseEffect LevelEvidence
1 gMildLimited clinical data
3 gOptimalClinical validation
5-9 gStrongSome studies
30+ gHigh-dose (psychiatric)Schizophrenia research
The 3g dose represents the sweet spot: clinically validated, achievable in beverages, and free of side effects.

GlyciWave Glycine Specification

AttributeSpecificationMethod
IdentityGlycine (Aminoacetic acid)HPLC, FTIR
Assay≥99.0%HPLC
AppearanceWhite crystalline powderVisual
SolubilityFreely soluble in waterFunctional
pH (5% solution)5.5-7.0Potentiometric
Loss on drying≤0.5%Gravimetric
Residue on ignition≤0.1%Gravimetric
Chloride≤0.02%Limit test
Sulfate≤0.02%Limit test
Heavy metals (total)≤10 ppmICP-MS
Lead≤1 ppmICP-MS
Arsenic≤1 ppmICP-MS
Mercury≤0.1 ppmICP-MS
Microbial (TPC)≤100 CFU/gUSP <61>
Yeast & Mold≤10 CFU/gUSP <61>
E. coliAbsentUSP <62>
SalmonellaAbsentUSP <62>

Molecular Identity

PropertyValue
IUPAC NameAminoacetic acid
SynonymsGlycine, Gly, G
Molecular FormulaC₂H₅NO₂
Molecular Weight75.07 g/mol
CAS Number56-40-6
StructureNH₂-CH₂-COOH

Manufacturing

ParameterSpecification
GradePharmaceutical / USP-NF
SynthesisFermentation or chemical
PurificationCrystallization
TestingFull CoA each batch

Why ≥99% Purity

Purity LevelApplicationNTRPX Standard
98%Food gradeBelow standard
≥99%Pharmaceutical gradeNTRPX standard
99.5%+Ultra-purePremium

Stability

ConditionStabilityShelf Life
Powder (sealed)Excellent3+ years
Solution (pH 5-7)ExcellentStable
Heat (pasteurization)ExcellentNo degradation
LightExcellentNo photosensitivity

The 3 Gram Standard

Clinical research consistently uses 3g glycine for sleep benefits:
StudyDoseOutcome
Inagawa 20063g↑ Subjective sleep quality
Yamadera 20073g↓ Sleep latency, ↑ cognition
Bannai 20123g↓ Fatigue, ↑ alertness
Kawai 20153g equivalentMechanism confirmed

Neuraldrink Protocol

ProductGlycine ContentContextTiming
Neuraldrink3,000 mg (3g)Evening beverage30-60 min before bed

Dose-Response Analysis

DoseSleep EffectCognitive EffectPracticality
1 gMildMinimalEasy
3 gClinically validatedEnhanced next-dayOptimal for beverage
5-9 gStrongUnknownLarge volume needed
30+ gPsychiatric applicationDifferent indicationNot for sleep

Why 3g Is the “Goldilocks Dose”

FactorRationale
Clinical validationAll positive sleep studies used 3g
Thermoregulation thresholdSufficient for 0.3°C temperature drop
Beverage compatibilityEasily dissolved in 250-350 mL
SafetyNo adverse events at this dose
TastePleasant sweetness, not excessive

Timing Optimization

TimingEffect
30 min before bedOptimal — peak effect at sleep onset
60 min before bedGood — allows full absorption
2 hours before bedAcceptable — peak may be early
With dinnerDelayed absorption; less optimal

Population Considerations

PopulationDoseNotes
Healthy adults3gStandard
Sleep difficulties3gPrimary indication
Elderly3gWell-tolerated; GSH benefit
Athletes (recovery)3-5gAdditional collagen support

Neuraldrink Stack Synergies

Glycine integrates with the Neuraldrink formula for comprehensive sleep and recovery support:

Glycine + L-Theanine: The Calm Stack

Both amino acids promote relaxation through complementary mechanisms:
CompoundMechanismCombined Benefit
GlycineGlyR inhibition, thermoregulationPhysical relaxation, sleep onset
L-TheanineAlpha waves, GABAMental calm, anxiety reduction
TogetherComplementary pathwaysProfound calm without sedation

Glycine + Magnesium: The Sleep Foundation

Magnesium RoleGlycine RoleCombined
NMDA modulationNMDA co-agonismBalanced NMDA function
Muscle relaxationNeural inhibitionPhysical relaxation
HPA axis supportCortisol modulationStress buffer

Glycine + Electrolytes

ElectrolyteGlycine SynergyBenefit
SodiumGlycine enhances absorptionHydration
PotassiumCellular functionMuscle relaxation
MagnesiumSee aboveSleep support

NTRPX Cross-Product Synergies

NTRPX ProductGlycine SynergyApplication
LunaGlycine in both (if present)Sleep stack completion
BoostGSH support complements energyRecovery support
RecoverCollagen synthesis, antioxidantPhysical recovery

Synergy Rating Summary

SynergyContextEvidenceRating
Glycine + L-TheanineNeuraldrinkLogical (strong)★★★★★
Glycine + MagnesiumNeuraldrinkLogical★★★★☆
Glycine + Sleep contextAnyStrong clinical★★★★★
Glycine + NAC (external)GSH supportClinical★★★★★
Glycine + Collagen (external)Structural supportLogical★★★★☆

Sleep Quality Trials

StudyDesignNDoseDurationFinding
Inagawa 2006Crossover153gAcute↑ Subjective sleep quality, ↓ fatigue
Yamadera 2007RCT, PSG113g2 nights↓ Sleep latency, ↓ SWS latency, ↑ cognition
Bannai 2012RCT103gRestricted sleep↓ Daytime sleepiness, ↑ alertness

Mechanism Studies

StudyModelFinding
Kawai 2015Rat, pharmacologicalNMDA receptors in SCN mediate thermoregulation
Bannai 2011RatGlycine activates SCN neurons
MultipleCutaneous blood flowPeripheral vasodilation confirmed

Next-Day Cognition

OutcomeStudyFinding
Memory recognitionYamadera 2007Improved
Fatigue (VAS)Inagawa 2006↓ 15%
Sleepiness (SSS)Bannai 2012↓ 29%
“Clear-headedness”Yamadera 2007Reported by subjects

Safety Data

StudyDoseAdverse Events
Inagawa 2006 (safety)Up to 9g acuteNone
Yamadera 20073gNone
High-dose studies31g+Minimal (mild GI)

Effect Size Summary

OutcomeEffect SizeEvidence Level
Sleep latency reductiond = 0.4-0.6Moderate-High
Subjective sleep qualityd = 0.5-0.7High
Next-day fatigued = 0.4-0.5Moderate
Next-day cognitiond = 0.3-0.5Moderate
Thermoregulation~0.3°C dropHigh (objective)

References

Sleep Studies:
  • Yamadera W et al. Glycine ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes. Sleep Biol Rhythms. 2007;5:126-131. DOI
  • Inagawa K et al. Subjective effects of glycine ingestion before bedtime on sleep quality. Sleep Biol Rhythms. 2006;4:75-77.
  • Bannai M et al. The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers. Front Neurol. 2012;3:61. PubMed
Mechanism:
  • Kawai N et al. The sleep-promoting and hypothermic effects of glycine are mediated by NMDA receptors in the suprachiasmatic nucleus. Neuropsychopharmacology. 2015;40(6):1405-16. PubMed
Safety:
  • Inagawa K et al. Assessment of acute adverse events of glycine ingestion at high doses in human volunteers. J Urban Life Health Assoc. 2006;50:27-32.

Adverse Event Profile

EventIncidenceSeverityNotes
GI discomfortRareMildAt very high doses
NauseaRareMildDose-dependent
Soft stoolsRareMildHigh doses
At the 3g clinical dose, no adverse events have been reported in controlled studies.

Safety Data

ParameterFinding
3g dose safetyNo adverse events in all clinical studies
9g acute doseWell-tolerated
31g single doseTolerated (some GI effects)
0.8 g/kg body weightTolerated in research
GRAS statusGenerally Recognized as Safe
LD50Very high; practically non-toxic

Regulatory Status

RegionStatusNotes
United StatesGRAS; dietary supplementEstablished safety
European UnionFood additive (E640)Approved
JapanFood additiveLong history
Codex AlimentariusPermittedInternational standard

Contraindications

CategoryConsiderationSeverity
ClozapineMay interfere with efficacy★★★★☆ Avoid without supervision
Severe kidney diseaseAmino acid metabolism★★★☆☆ Consult provider
Pregnancy/NursingLimited specific data★★☆☆☆ Consult provider

Drug Interactions

Drug ClassInteractionSeverityNotes
ClozapineMay reduce efficacy★★★★☆Avoid combination
Other antipsychoticsTheoretical NMDA effects★★☆☆☆Monitor
SedativesAdditive calming★★☆☆☆May enhance effect

Special Populations

PopulationSafety StatusNotes
Healthy adultsExcellentPrimary use
ElderlyExcellentMay benefit from GSH support
AthletesExcellentRecovery support
Sleep difficultiesExcellentPrimary indication
Clozapine usersContraindicatedSpecific interaction
PregnancyCautionConsult provider

Tier 1: Foundation

Efficacy

High

Validation

Strong — Multiple RCTs; mechanism elucidated

Safety

Excellent — GRAS status; no adverse events at 3g
Tier Rationale: Tier 1 (Foundation) classification. Glycine is one of the most well-validated natural sleep aids, with multiple RCTs demonstrating benefits at the 3g dose for sleep onset, sleep quality, and next-day cognition. The mechanism is uniquely elegant: NMDA-mediated thermoregulation via the suprachiasmatic nucleus — working with natural sleep physiology rather than overriding it. This explains why glycine improves rather than impairs next-day function. Additional benefits as a glutathione precursor, NMDA co-agonist, and inhibitory neurotransmitter add multi-dimensional value. Safety is excellent with GRAS status and no adverse events at clinical doses. Exceptional beverage compatibility (solubility, sweetness, stability) makes glycine ideal for Neuraldrink’s format.

When to Use Neuraldrink with Glycine

ScenarioExpected BenefitProtocol
Sleep optimizationHigh1 Neuraldrink (3g glycine), 30-60 min before bed
Sleep onset difficultiesHighConsistent evening use
Next-day performanceHighEvening dose improves morning cognition
Sleep restriction periodsHighReduces fatigue, improves alertness
Travel/jet lagModerateSupports sleep adjustment
Recovery (athletes)ModerateCollagen, GSH support

Realistic Expectations

TimeframeWhat to Expect
Night 1Often noticeable — faster sleep onset
Night 3-5Consistent improvement; reduced fatigue
Night 7+Full effect — optimized sleep + cognition
OngoingSustained benefits with continued use

Signs It’s Working

IndicatorDescription
Faster sleep onsetLess time lying awake
Better sleep qualityMore restful, deeper sleep
Easier wake-upLess groggy in morning
Improved energyLess daytime fatigue
Better focusEnhanced morning cognition
”Clear-headedness”Reported subjective quality

Optimizing Response

StrategyRationale
30-60 min before bedPeak effect at sleep onset
Consistent timingReinforces sleep routine
Cool environmentSupports thermoregulation
Dim lightsComplements circadian signaling
Avoid late caffeineDon’t counteract calming effects

Frequently Asked Questions

Sleeping pills (benzodiazepines, Z-drugs) work by forcing GABA-A sedation, which disrupts natural sleep architecture and impairs next-day function. Glycine works through natural thermoregulation — lowering core temperature via the brain’s circadian clock (SCN). This preserves normal sleep stages and actually enhances next-day cognition. It’s the difference between being sedated and being helped to fall asleep naturally.
No — the opposite is true. Clinical studies show glycine improves next-day cognition, reduces fatigue, and increases alertness. Subjects report feeling “clear-headed,” “lively,” and “peppy” the morning after glycine. This is unique among sleep aids.
3 grams is the clinically-validated dose — all positive sleep studies used this amount. It’s the threshold needed to trigger the 0.3°C temperature drop that initiates sleep. Higher doses (up to 9g) have been studied for safety but don’t show additional sleep benefits. The 3g dose is the “Goldilocks” zone: effective, safe, and beverage-compatible.
Most people notice effects on the first or second night. Peak thermoregulatory effect occurs about 30-60 minutes after ingestion. Full benefits, especially for next-day cognition, build over the first week of consistent use.
Yes. Glycine works through thermoregulation (NMDA/SCN) while most other sleep supplements work through GABA pathways. They’re complementary. In Neuraldrink, glycine synergizes well with L-Theanine and Magnesium. The calming effects may be additive, so start with recommended doses.
Glycine’s name comes from Greek glykys meaning “sweet.” Its molecular structure activates sweet taste receptors, providing about 70% the sweetness of sugar. This natural sweetness helps Neuraldrink taste pleasant without excessive added sweeteners.
Yes. Glycine is a precursor to glutathione (master antioxidant), essential for collagen synthesis (skin, joints, bones), and involved in creatine production (muscle energy). It also acts as an inhibitory neurotransmitter (calming) and NMDA co-agonist (learning, memory). The 3g dose in Neuraldrink supports all these pathways.

GlyciWave Summary: Glycine (3,000mg in Neuraldrink) is a clinically-validated sleep enhancer that works through a unique thermoregulatory mechanism — activating NMDA receptors in the brain’s master clock (SCN) to lower core body temperature and trigger natural sleep onset. Unlike sedatives that impair next-day function, glycine enhances morning cognition, reduces fatigue, and improves alertness. Additional benefits as a glutathione precursor, NMDA co-agonist for learning, and inhibitory neurotransmitter make it multi-functional. Its exceptional water solubility and natural sweetness make glycine the ideal functional beverage ingredient. In Neuraldrink, GlyciWave delivers the full clinical dose for better sleep tonight and a sharper tomorrow.